Faecal calprotectin

Structure and function

Calprotectin is a 24 kDa protein dimer of S100A8 and S100A9. The complex accounts for up to 60% of the soluble protein content of the neutrophil cytosol. In vitro studies show that calprotectin has bacteriostatic and fungistatic properties, that arise from the ability to sequester manganese and zinc ions. Calprotectin has two transition metal binding sites that form at the interface of the S100A8 and S100A9 monomers, and metal sequestration by calprotectin has been shown to be calcium dependent. The complex is resistant to enzymatic degradation, and can be easily measured in faeces.

Use as a surrogate marker

The main diseases that cause an increased excretion of faecal calprotectin are inflammatory bowel diseases (IBD), coeliac disease, infectious colitis, necrotizing enterocolitis in infants, intestinal cystic fibrosis and colorectal cancer.

Faecal calprotectin is regularly used as indicator for IBD during treatment and as a diagnostic marker. IBD are a group of conditions that cause a pathological inflammation of the bowel wall. Crohn's disease and ulcerative colitis are the principal types of inflammatory bowel disease. Inflammatory processes result in an influx of neutrophils into the bowel lumen. Since calprotectin comprises as much as 60% of the soluble protein content of the cytosol of neutrophils, it can serve as a marker for the level of intestinal inflammation. Measurement of faecal calprotectin has been shown to be strongly correlated with 111-indium-labelled leucocytes – considered the gold standard measurement of intestinal inflammation.

Levels of faecal calprotectin are usually normal in patients with irritable bowel syndrome (IBS). In untreated coeliac disease, concentration levels of faecal calprotectin correlate with the degree of intestinal mucosal lesion and normalize with a gluten-free diet. High fecal calprotectin is a common finding among hospitalized coronavirus disease 2019 (COVID-19) patients, especially those with SARS-CoV-2 fecal shedding.

Faecal calprotectin is measured using immunochemical techniques such as ELISA or immunochromatographic assays. The antibodies used in these assays target specific epitopes of the calprotectin molecule.

Increased faecal calprotectin may be indicative of intestinal tuberculosis or pulmonary tuberculosis.

False-positive measurements

Although faecal calprotectin correlates significantly with disease activity in people with confirmed IBD, faecal calprotectin can be false-positive if the laboratory uses low calprotectin cut-off levels.

References

References

1. (October 2000). "A simple method for assessing intestinal inflammation in Crohn's disease". Gut.
2. (May 2010). "Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers". Annals of Clinical Biochemistry.
3. (2013). "The role of calprotectin in pediatric disease". BioMed Research International.
4. (June 2006). "Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease". Inflammatory Bowel Diseases.
5. (2016-01-28). "Fecal calprotectin in inflammatory bowel disease". Clinical and Experimental Gastroenterology.
6. (2004-01-01). "Calprotectin - a pleiotropic molecule in acute and chronic inflammation". Physiological Research.
7. (September 2003). "Role of faecal calprotectin as non-invasive marker of intestinal inflammation". Digestive and Liver Disease.
8. (November 2013). "Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation". [[Health Technology Assessment (journal).
9. (June 2021). "High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study". World Journal of Gastroenterology.
10. (October 2014). "Faecal calprotectin levels differentiate intestinal from pulmonary tuberculosis: An observational study from Southern India". United European Gastroenterology Journal.
11. (January 2009). "Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease". Digestive and Liver Disease.
12. (March 2015). "Manganese and microbial pathogenesis: sequestration by the Mammalian immune system and utilization by microorganisms". ACS Chemical Biology.
13. (2014). "Biomarkers in toxicology". Academic Press.
14. (2014). "Clinical Biochemistry: Metabolic and Clinical Aspects". Elsevier Health Sciences, 2014.